A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors
A phase 1/2 trial of JS105, Fulvestrant, Dalpiciclib, Toripalimab, Pyrotinib and Capecitabine in advanced solid tumours, run by Risen (Suzhou) Pharma Tech Co., Ltd., now recruiting.
Overview
A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors is a phase 1/2 interventional study registered as NCT06208410 by Risen (Suzhou) Pharma Tech Co., Ltd., with 306 participants planned, started 2024-01-11 and due to reach its primary completion in 2027-02-26. Interventions recorded: JS105, Fulvestrant injection, Dalpiciclib Isetionate Tablets, Toripalimab Injection, Paclitaxel for Injection (Albumin Bound) and Fluzoparib Capsules.
Similar pages
not linked directly; found by shared links- TrialA Study of Evaluating The Effects Of Pyrotinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
Shares Pyrotinib, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialClinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in Patients With Unresectable or Metastatic Breast Cancer
Shares Dalpiciclib, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study
Shares Toripalimab, Capecitabine, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors.
Shares Pyrotinib, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialPhase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors
Shares Toripalimab, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of WX390 Combined With Toripalimab in Patients With Advanced Solid Tumors
Shares Toripalimab, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer
Shares Fulvestrant, Capecitabine, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialPhase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
Shares Fulvestrant, Metastatic cancer (cancer that has spread) and the tag pipeline.